FDA Asked To Probe 3M's MRSA Clinical Test Conduct
Private equity firm Porton Group said Wednesday that it would ask the U.S. Food and Drug Administration to investigate 3M Co.'s alleged mishandling of clinical trials for a MRSA detection device...To view the full article, register now.
Already a subscriber? Click here to view full article